CORONAVIRUS RESEARCH
Georgia State scientists were the first to demonstrate that molnupiravir was orally active against SARS-CoV-2. The antiviral drug has been recommended for emergency use authorization to treat COVID-19.
With a grant from the CDC, Georgia State’s Prevention Research Center is working to increase COVID-19 vaccination rates among refugees and other groups in Clarkston — one of the largest refugee resettlement communities in the U.S.
Juan Banda, assistant professor in the Department of Computer Science, is tapping into Twitter data to learn more about people’s experiences during the pandemic.
Georgia State researchers are teaming up with their colleagues at Emory School of Medicine to help nursing homes mitigate the impact of COVID-19 and stop the spread of SARS-CoV-2.
Team Up With Our Researchers
Interested in collaborating with Georgia State scientists on coronavirus research? Contact our Office of Technology Transfer and Commercialization.
Subscribe To Our Newsletter
Subscribe to our research magazine and monthly e-newsletter and see how we’re making discoveries #THESTATEWAY®
Contact Us
Donald Hamelberg
Vice President for Research and Economic Development
[email protected]
Noelle Toumey Reetz
Communications Manager
[email protected]
Research Administration
(404) 413-3500
[email protected]